The double-edged sword of Notch signaling in cancer
Authors:
- 1 June 2012
- journal article
- review article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 23 (4) , 458-464
Abstract
No abstract availableKeywords
Funding Information
- the National Institutes of Health and the Leukemia and Lymphoma Society (J.C.A.)
- the Dermatology Foundation (R.J.C.)
- DebRA International and the British Skin Foundation (A.P.S.)
This publication has 49 references indexed in Scilit:
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2011
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerNature Medicine, 2011
- IRF6 is a mediator of Notch pro‐differentiation and tumour suppressive function in keratinocytesThe EMBO Journal, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- A novel tumour-suppressor function for the Notch pathway in myeloid leukaemiaNature, 2011
- Alterations of the Notch pathway in lung cancerProceedings of the National Academy of Sciences, 2009
- Epidermal Notch1 Loss Promotes Skin Tumorigenesis by Impacting the Stromal MicroenvironmentCancer Cell, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cellsProceedings of the National Academy of Sciences, 2007
- Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in miceProceedings of the National Academy of Sciences, 2006